Broader Epstein-Barr virus-specific T cell receptor repertoire in patients with multiple sclerosis. 2022

Tilman Schneider-Hohendorf, and Lisa Ann Gerdes, and Béatrice Pignolet, and Rachel Gittelman, and Patrick Ostkamp, and Florian Rubelt, and Catarina Raposo, and Björn Tackenberg, and Marianne Riepenhausen, and Claudia Janoschka, and Christian Wünsch, and Florence Bucciarelli, and Andrea Flierl-Hecht, and Eduardo Beltrán, and Tania Kümpfel, and Katja Anslinger, and Catharina C Gross, and Heidi Chapman, and Ian Kaplan, and David Brassat, and Hartmut Wekerle, and Martin Kerschensteiner, and Luisa Klotz, and Jan D Lünemann, and Reinhard Hohlfeld, and Roland Liblau, and Heinz Wiendl, and Nicholas Schwab
Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany.

Epstein-Barr virus (EBV) infection precedes multiple sclerosis (MS) pathology and cross-reactive antibodies might link EBV infection to CNS autoimmunity. As an altered anti-EBV T cell reaction was suggested in MS, we queried peripheral blood T cell receptor β chain (TCRβ) repertoires of 1,395 MS patients, 887 controls, and 35 monozygotic, MS-discordant twin pairs for multimer-confirmed, viral antigen-specific TCRβ sequences. We detected more MHC-I-restricted EBV-specific TCRβ sequences in MS patients. Differences in genetics or upbringing could be excluded by validation in monozygotic twin pairs discordant for MS. Anti-VLA-4 treatment amplified this observation, while interferon β- or anti-CD20 treatment did not modulate EBV-specific T cell occurrence. In healthy individuals, EBV-specific CD8+ T cells were of an effector-memory phenotype in peripheral blood and cerebrospinal fluid. In MS patients, cerebrospinal fluid also contained EBV-specific central-memory CD8+ T cells, suggesting recent priming. Therefore, MS is not only preceded by EBV infection, but also associated with broader EBV-specific TCR repertoires, consistent with an ongoing anti-EBV immune reaction in MS.

UI MeSH Term Description Entries
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D004854 Herpesvirus 4, Human The type species of LYMPHOCRYPTOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans. It is thought to be the causative agent of INFECTIOUS MONONUCLEOSIS and is strongly associated with oral hairy leukoplakia (LEUKOPLAKIA, HAIRY;), BURKITT LYMPHOMA; and other malignancies. Burkitt Herpesvirus,Burkitt Lymphoma Virus,E-B Virus,EBV,Epstein-Barr Virus,Human Herpesvirus 4,Infectious Mononucleosis Virus,Burkitt's Lymphoma Virus,HHV-4,Herpesvirus 4 (gamma), Human,Burkitts Lymphoma Virus,E B Virus,E-B Viruses,Epstein Barr Virus,Herpesvirus, Burkitt,Infectious Mononucleosis Viruses,Lymphoma Virus, Burkitt,Mononucleosis Virus, Infectious,Mononucleosis Viruses, Infectious
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016693 Receptors, Antigen, T-Cell, alpha-beta T-cell receptors composed of CD3-associated alpha and beta polypeptide chains and expressed primarily in CD4+ or CD8+ T-cells. Unlike immunoglobulins, the alpha-beta T-cell receptors recognize antigens only when presented in association with major histocompatibility (MHC) molecules. Antigen Receptors, T-Cell, alpha-beta,T-Cell Receptors alpha-Chain,T-Cell Receptors beta-Chain,T-Cell Receptors, alpha-beta,TcR alpha-beta,Antigen T Cell Receptor, alpha Chain,Antigen T Cell Receptor, beta Chain,Receptors, Antigen, T Cell, alpha beta,T Cell Receptors, alpha beta,T-Cell Receptor alpha-Chain,T-Cell Receptor beta-Chain,T-Cell Receptor, alpha-beta,T Cell Receptor alpha Chain,T Cell Receptor beta Chain,T Cell Receptor, alpha beta,T Cell Receptors alpha Chain,T Cell Receptors beta Chain,TcR alpha beta,alpha-Chain, T-Cell Receptor,alpha-Chain, T-Cell Receptors,alpha-beta T-Cell Receptor,alpha-beta T-Cell Receptors,alpha-beta, TcR,beta-Chain, T-Cell Receptor,beta-Chain, T-Cell Receptors
D018414 CD8-Positive T-Lymphocytes A critical subpopulation of regulatory T-lymphocytes involved in MHC Class I-restricted interactions. They include both cytotoxic T-lymphocytes (T-LYMPHOCYTES, CYTOTOXIC) and CD8+ suppressor T-lymphocytes. Suppressor T-Lymphocytes, CD8-Positive,T8 Cells,T8 Lymphocytes,CD8-Positive Lymphocytes,Suppressor T-Cells, CD8-Positive,CD8 Positive Lymphocytes,CD8 Positive T Lymphocytes,CD8-Positive Lymphocyte,CD8-Positive Suppressor T-Cell,CD8-Positive Suppressor T-Cells,CD8-Positive Suppressor T-Lymphocyte,CD8-Positive Suppressor T-Lymphocytes,CD8-Positive T-Lymphocyte,Cell, T8,Cells, T8,Lymphocyte, CD8-Positive,Lymphocyte, T8,Lymphocytes, CD8-Positive,Lymphocytes, T8,Suppressor T Cells, CD8 Positive,Suppressor T Lymphocytes, CD8 Positive,Suppressor T-Cell, CD8-Positive,Suppressor T-Lymphocyte, CD8-Positive,T-Cell, CD8-Positive Suppressor,T-Cells, CD8-Positive Suppressor,T-Lymphocyte, CD8-Positive,T-Lymphocyte, CD8-Positive Suppressor,T-Lymphocytes, CD8-Positive,T-Lymphocytes, CD8-Positive Suppressor,T8 Cell,T8 Lymphocyte
D020031 Epstein-Barr Virus Infections Infection with human herpesvirus 4 (HERPESVIRUS 4, HUMAN); which may facilitate the development of various lymphoproliferative disorders. These include BURKITT LYMPHOMA (African type), INFECTIOUS MONONUCLEOSIS, and oral hairy leukoplakia (LEUKOPLAKIA, HAIRY). EBV Infections,Epstein-Barr Virus Infection,Herpesvirus 4 Infections, Human,Human Herpes Virus 4 Infections,Human Herpesvirus 4 Infections,Infections, EBV,Infections, Epstein-Barr Virus,EBV Infection,Epstein Barr Virus Infection,Epstein Barr Virus Infections,Infection, EBV,Infection, Epstein-Barr Virus,Virus Infection, Epstein-Barr,Virus Infections, Epstein-Barr

Related Publications

Tilman Schneider-Hohendorf, and Lisa Ann Gerdes, and Béatrice Pignolet, and Rachel Gittelman, and Patrick Ostkamp, and Florian Rubelt, and Catarina Raposo, and Björn Tackenberg, and Marianne Riepenhausen, and Claudia Janoschka, and Christian Wünsch, and Florence Bucciarelli, and Andrea Flierl-Hecht, and Eduardo Beltrán, and Tania Kümpfel, and Katja Anslinger, and Catharina C Gross, and Heidi Chapman, and Ian Kaplan, and David Brassat, and Hartmut Wekerle, and Martin Kerschensteiner, and Luisa Klotz, and Jan D Lünemann, and Reinhard Hohlfeld, and Roland Liblau, and Heinz Wiendl, and Nicholas Schwab
November 2018, JCI insight,
Tilman Schneider-Hohendorf, and Lisa Ann Gerdes, and Béatrice Pignolet, and Rachel Gittelman, and Patrick Ostkamp, and Florian Rubelt, and Catarina Raposo, and Björn Tackenberg, and Marianne Riepenhausen, and Claudia Janoschka, and Christian Wünsch, and Florence Bucciarelli, and Andrea Flierl-Hecht, and Eduardo Beltrán, and Tania Kümpfel, and Katja Anslinger, and Catharina C Gross, and Heidi Chapman, and Ian Kaplan, and David Brassat, and Hartmut Wekerle, and Martin Kerschensteiner, and Luisa Klotz, and Jan D Lünemann, and Reinhard Hohlfeld, and Roland Liblau, and Heinz Wiendl, and Nicholas Schwab
October 2020, JCI insight,
Tilman Schneider-Hohendorf, and Lisa Ann Gerdes, and Béatrice Pignolet, and Rachel Gittelman, and Patrick Ostkamp, and Florian Rubelt, and Catarina Raposo, and Björn Tackenberg, and Marianne Riepenhausen, and Claudia Janoschka, and Christian Wünsch, and Florence Bucciarelli, and Andrea Flierl-Hecht, and Eduardo Beltrán, and Tania Kümpfel, and Katja Anslinger, and Catharina C Gross, and Heidi Chapman, and Ian Kaplan, and David Brassat, and Hartmut Wekerle, and Martin Kerschensteiner, and Luisa Klotz, and Jan D Lünemann, and Reinhard Hohlfeld, and Roland Liblau, and Heinz Wiendl, and Nicholas Schwab
April 2006, Clinical immunology (Orlando, Fla.),
Tilman Schneider-Hohendorf, and Lisa Ann Gerdes, and Béatrice Pignolet, and Rachel Gittelman, and Patrick Ostkamp, and Florian Rubelt, and Catarina Raposo, and Björn Tackenberg, and Marianne Riepenhausen, and Claudia Janoschka, and Christian Wünsch, and Florence Bucciarelli, and Andrea Flierl-Hecht, and Eduardo Beltrán, and Tania Kümpfel, and Katja Anslinger, and Catharina C Gross, and Heidi Chapman, and Ian Kaplan, and David Brassat, and Hartmut Wekerle, and Martin Kerschensteiner, and Luisa Klotz, and Jan D Lünemann, and Reinhard Hohlfeld, and Roland Liblau, and Heinz Wiendl, and Nicholas Schwab
January 2017, Clinical & translational immunology,
Tilman Schneider-Hohendorf, and Lisa Ann Gerdes, and Béatrice Pignolet, and Rachel Gittelman, and Patrick Ostkamp, and Florian Rubelt, and Catarina Raposo, and Björn Tackenberg, and Marianne Riepenhausen, and Claudia Janoschka, and Christian Wünsch, and Florence Bucciarelli, and Andrea Flierl-Hecht, and Eduardo Beltrán, and Tania Kümpfel, and Katja Anslinger, and Catharina C Gross, and Heidi Chapman, and Ian Kaplan, and David Brassat, and Hartmut Wekerle, and Martin Kerschensteiner, and Luisa Klotz, and Jan D Lünemann, and Reinhard Hohlfeld, and Roland Liblau, and Heinz Wiendl, and Nicholas Schwab
January 2017, The Egyptian journal of immunology,
Tilman Schneider-Hohendorf, and Lisa Ann Gerdes, and Béatrice Pignolet, and Rachel Gittelman, and Patrick Ostkamp, and Florian Rubelt, and Catarina Raposo, and Björn Tackenberg, and Marianne Riepenhausen, and Claudia Janoschka, and Christian Wünsch, and Florence Bucciarelli, and Andrea Flierl-Hecht, and Eduardo Beltrán, and Tania Kümpfel, and Katja Anslinger, and Catharina C Gross, and Heidi Chapman, and Ian Kaplan, and David Brassat, and Hartmut Wekerle, and Martin Kerschensteiner, and Luisa Klotz, and Jan D Lünemann, and Reinhard Hohlfeld, and Roland Liblau, and Heinz Wiendl, and Nicholas Schwab
January 2019, Molecular immunology,
Tilman Schneider-Hohendorf, and Lisa Ann Gerdes, and Béatrice Pignolet, and Rachel Gittelman, and Patrick Ostkamp, and Florian Rubelt, and Catarina Raposo, and Björn Tackenberg, and Marianne Riepenhausen, and Claudia Janoschka, and Christian Wünsch, and Florence Bucciarelli, and Andrea Flierl-Hecht, and Eduardo Beltrán, and Tania Kümpfel, and Katja Anslinger, and Catharina C Gross, and Heidi Chapman, and Ian Kaplan, and David Brassat, and Hartmut Wekerle, and Martin Kerschensteiner, and Luisa Klotz, and Jan D Lünemann, and Reinhard Hohlfeld, and Roland Liblau, and Heinz Wiendl, and Nicholas Schwab
August 2014, The Journal of the Egyptian Public Health Association,
Tilman Schneider-Hohendorf, and Lisa Ann Gerdes, and Béatrice Pignolet, and Rachel Gittelman, and Patrick Ostkamp, and Florian Rubelt, and Catarina Raposo, and Björn Tackenberg, and Marianne Riepenhausen, and Claudia Janoschka, and Christian Wünsch, and Florence Bucciarelli, and Andrea Flierl-Hecht, and Eduardo Beltrán, and Tania Kümpfel, and Katja Anslinger, and Catharina C Gross, and Heidi Chapman, and Ian Kaplan, and David Brassat, and Hartmut Wekerle, and Martin Kerschensteiner, and Luisa Klotz, and Jan D Lünemann, and Reinhard Hohlfeld, and Roland Liblau, and Heinz Wiendl, and Nicholas Schwab
September 2009, Current neurology and neuroscience reports,
Tilman Schneider-Hohendorf, and Lisa Ann Gerdes, and Béatrice Pignolet, and Rachel Gittelman, and Patrick Ostkamp, and Florian Rubelt, and Catarina Raposo, and Björn Tackenberg, and Marianne Riepenhausen, and Claudia Janoschka, and Christian Wünsch, and Florence Bucciarelli, and Andrea Flierl-Hecht, and Eduardo Beltrán, and Tania Kümpfel, and Katja Anslinger, and Catharina C Gross, and Heidi Chapman, and Ian Kaplan, and David Brassat, and Hartmut Wekerle, and Martin Kerschensteiner, and Luisa Klotz, and Jan D Lünemann, and Reinhard Hohlfeld, and Roland Liblau, and Heinz Wiendl, and Nicholas Schwab
January 2021, Frontiers in neurology,
Tilman Schneider-Hohendorf, and Lisa Ann Gerdes, and Béatrice Pignolet, and Rachel Gittelman, and Patrick Ostkamp, and Florian Rubelt, and Catarina Raposo, and Björn Tackenberg, and Marianne Riepenhausen, and Claudia Janoschka, and Christian Wünsch, and Florence Bucciarelli, and Andrea Flierl-Hecht, and Eduardo Beltrán, and Tania Kümpfel, and Katja Anslinger, and Catharina C Gross, and Heidi Chapman, and Ian Kaplan, and David Brassat, and Hartmut Wekerle, and Martin Kerschensteiner, and Luisa Klotz, and Jan D Lünemann, and Reinhard Hohlfeld, and Roland Liblau, and Heinz Wiendl, and Nicholas Schwab
March 2024, Nature reviews. Neurology,
Copied contents to your clipboard!